Therefore, there is a compelling need for more reliable in vivo preclinical models for studying the disease and for testing new drugs and therapies, and this reliable model should replicate human GBM biological properties with high invasiveness and overexpression of EGFR, one of major genes relevant to its high malignancy. Here, EGFR is linked to glioblastoma.